MR1 anticorps (AA 312-341) (APC)

N° du produit ABIN1914621

Détail du produit anti-MR1 anticorps (APC)

Antigène: MR1 (Major Histocompatibility Complex, Class I-Related (MR1))

Épitope: AA 312-341

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp MR1 est conjugé à/à la APC

Application: ELISA, Western Blotting (WB)

Specificité: This MR1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 312-341 amino acids from the C-terminal region of human MR1.

Purification: Protein A purified

Isotype: IgG

Information d'application

Indications d'application: Approved: ELISA, WB

Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.

Commentaires:

Target Species of Antibody: Human

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: PBS, no preservatives added

Agent conservateur: Without preservative

Conseil sur la manipulation: Aliquot to avoid repeated freezing and thawing.

Stock: 4 °C,-20 °C

Stockage commentaire: Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.

Date de péremption: 6 months

Détails sur MR1

Antigène: MR1 (Major Histocompatibility Complex, Class I-Related (MR1))

Autre désignation: MR1 (MR1 Produits)

Synonymes: anticorps YFV, anticorps hlals, anticorps MGC154362, anticorps MR1, anticorps DKFZp468C1823, anticorps HLALS, anticorps H2ls, anticorps Hlals, anticorps MHC class I antigen YF5, anticorps major histocompatibility complex, class I-related, anticorps major histocompatibility complex, class I-related L homeolog, anticorps YF5, anticorps MR1, anticorps mr1.L, anticorps mr1, anticorps Mr1

Sujet: Name/Gene ID: MR1

Synonyms: MR1, HLALS, MHC class I-like antigen MR-1

ID gène: 3140

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints